The AD8 questionnaire developed by Washington University in St Louis is a screening tool with 8 questions to reliably differentiate nondemented from demented individuals even at the very mild stage. We recruited 239 participants, including 114 cognitively normal, 73 very mild dementia, and 52 mild dementia to validate its application in Taiwanese. The cut-off value of AD8 was 2 in discriminating cognitively normal from demented individuals with the area under curve (AUC) = 0.961, sensitivity = 97.6%, specificity = 78.1%, positive likelihood ratio (PLR) = 4.5, and negative likelihood ratio (NLR) = 0.03. The cut-off value also was 2 in discriminating nondemented from very mild dementia with the AUC = 0.948, sensitivity = 95.9%, specificity = 78.1%, PLR = 4.4, and NLR = 0.05. The Chinese AD8 is effective in discriminating individuals with dementia, even at its mildest stages from those without dementia with properties identical to the original English version. The cAD8 is a quick dementia screening tool that can be applied across cultures.
Ferri CP, Prince M., Brayne C., et al. Global prevalence of dementia: a Delphi consensus study. Lancet2005;366(9503):2112-2117.
2.
Gauthier SGAlzheimer’s disease: the benefits of early treatment. Eur J Neurol. 2005;12(suppl 3):11-16.
3.
Hodges JRAlzheimer’s centennial legacy: origins, landmarks and the current status of knowledge concerning cognitive aspects. Brain. 2006;129(pt 11):2811-2822.
4.
Leifer BPAlzheimer’s disease: seeing the signs early. J Am Acad Nurse Pract.2009;21(11):588-595.
5.
Yang YH, Lai CL, Lin RT, et al. Prevalence and demographic characteristics of mild cognitive impairment: a community-based study in Taiwan. Paper presented at the 57th American Academy of Neurology Annual Meeting; April 13, 2005; Miami.
6.
Bennett DA, Wilson RS, Schneider JA, et al. Natural history of mild cognitive impairment in older persons . Neurology. 2002;59(2):198-205.
7.
McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan EMClinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology. 1984;34(7):939-944.
8.
Folstein MF, Folstein SE, McHugh PRMini-mental state: a practical method for grading the cognitive state of patients for the clinicians. J Psychiatr Res. 1975;12(3):189-198.
9.
Lawrence J., Davidoff D., Katt-Lloyd D., Auerbach M., Hennen J.A pilot program of improved methods for community-based screening for dementia . Am J Geriatr Psychiatry. 2001;9(3):205-211.
10.
Liu HC, Teng EL, Lin KN, et al. Performance on the Cognitive Abilities Screening Instrument at Different Stages of Alzheimer’s Disease. Dement Geriatr Cogn Disord. 2002;13(4):244-248.
11.
Powlishta KK , Von Dras DD, Stanford A., et al. The clock drawing test is a poor screen for very mild dementia. Neurology. 2002;59(6):898-903.
12.
Yamamoto S. , Mogi N., Umegaki H., et al. The clock drawing test as a valid screening method for mild cognitive impairment. Dem Geriatr Cogn Disord. 2004;18(2):172-179.
13.
Morris JC, McKeel DW, Storandt M., et al. Very mild Alzheimer’s disease: Informant-based clinical, psychometric and pathologic distinction from normal aging. Neurology. 1991;41(4):469-478.
14.
Morris JCThe Clinical dementia rating (CDR) - current version and scoring rules. Neurology. 1993;43(11):2412-2414.
15.
Morris JC, McKeel DW, Fulling K., Torack RM, Berg L.Validation of clinical diagnostic criteria for Alzheimer’s disease. Ann Neurol. 1988;24(1):17-22.
16.
Fuh JL, Teng EL, Lin KN, et al. The Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) as a screening tool for dementia for a predominantly illiterate Chinese population. Neurology. 1995;45(1):92-96.
17.
Galvin JE, Roe CM, Powlishta KK, et al. The AD8: a brief informant interview to detect dementia. Neurology. 2005;65(4): 559-564.
18.
Galvin JE, Roe CM, Coats MA, Morris JCPatient’s rating of cognitive ability. Using the AD8, a Brief Informant Interview, as a Self-rating Tool to Detect Dementia. Arch Neurol. 2007;64(5):725-730.
19.
Ryu HJ, Kim HJ, Han SHValidity and reliability of the Korean version of the AD8 informant interview (K-AD8) in dementia. Alzheimer Dis Assoc Disord.2009;23(4):371-376.
20.
Storandt M. , Grant EA, Miller JP, Morris JCLongitudinal course and neuropathologic outcomes in original vs revised MCI and in pre-MCI. Neurology. 2006;67(3):467-473.
21.
American Psychiatric Association.Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association; 1994.
22.
Guillemin F. , Bombardier C., Beaton D.Cross-cultural adaptation of health-related quality of life measures: literature review and proposed guidelines. J Clin Epidemiol. 1993;46(12):1417-1432.
23.
Morris JC, Berg L., Cohen LA, et al. In: Bergener M, Finkel SI, eds. Treating Alzheimer’s and Other Dementias: Clinical Application of Recent Research Advances. New York, NY: Springer Publishing; 1995:338-346.
24.
Lam LC, Tam CW, Lui VW, et al. Use of clinical dementia rating in detecting early cognitive deficits in a community-based sample of Chinese older persons in Hong Kong . Alzheimer Dis Assoc Disord. 2008;22(2):153-157.
25.
Galvin JE, Roe CM, Xiong C., Morris JCValidity and reliability of the AD8 informant interview in dementia. Neurology. 2006;67(11):1942-1948.
26.
Jost BC, Grossberg GTThe evolution of psychiatric symptoms in Alzheimer’s disease: a natural history study. J Am Geriatr Soc. 1996;44(9):1078-1081.
